Pursuant to Regulation 30, enclosed please find the Postal Ballot Notice dated September 22, 2025, for seeking the approval of the members by way of Ordinary and Special Resolutions, respectively ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GKB Ophthalmics is seeking shareholder approval via postal ballot (e-voting from October 3 to November 1, 2025) on two items. The first is an ordinary resolution to approve a material related party transaction worth Rs. 15 crores (13.76% of consolidated turnover) linked to winding up its 79.54%-owned material subsidiary, GSV Ophthalmics Private Limited. The second is a special resolution approving the voluntary winding up of GSV, which was incorporated to manufacture Hi-Index Lenses with a South Korean joint venture partner but never commenced operations due to COVID-19 disruptions and cost overruns. GKB had invested Rs. 11.70 crores in GSV's equity, currently parked in bank fixed deposits, which will be returned upon liquidation along with any surplus. GSV also holds an unsecured loan of Rs. 5 crores given to GKB, which will be repaid during the liquidation process. Results are expected to be announced on or before November 3, 2025.
This is a corporate clean-up exercise to wind up a dormant, never-operational subsidiary. Shareholders should view it neutrally to mildly positive as it simplifies the group structure and recovers idle capital of Rs. 11.70 crores plus any surplus, with no impact on GKB's core ophthalmics business operations.